Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
Sort by
Sort ascending
Study title
Condition
Phase
Location
NCT ID
Study title
Condition
Phase
Location
NCT ID
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Hematologic Malignancy, Solid Tumor, Advanced Malignancies
Phase3
Belgium Italy NetherlandsUnited Kingdom United States
View all
NCT06401356
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Relapsing Multiple Sclerosis (RMS)
Phase3
United States
NCT06869785
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Chagas Disease
Phase2
Argentina Brazil ColombiaUnited States
View all
NCT06632600
Modifying PEST for Psoriatic Arthritis Screening
Plaque Psoriasis, Psoriatic Arthritis
Na
Canada
NCT06382051
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
Follicular Lymphoma (FL)
Phase3
Australia Austria CanadaCzechia Hungary Poland Romania Singapore Slovakia South Korea Spain Taiwan United States
View all
NCT05888493
Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation
Hidradenitis Suppurativa
Russia
NCT06517732
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Alzheimer's Disease
Phase2
Canada United Kingdom United States
NCT07094516
A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation
HR+HER2- Advanced Breast Cancer
Russia
NCT06625333
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase1, Phase2
France Japan United States
NCT06704269
Long-term Follow up Local Registry Study of Kymriah in South Korea
B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
South Korea
NCT06785818
No matching countries found
Search